The shareholder litigation is being resolved through voluntary supplemental disclosures, removing a near-term closing risk. The October 15 special meetings are the next binary catalyst, monitor for preliminary vote counts or any last-minute opposition.
Price Chart
Executive Summary
Indivior filed a supplemental 8-K/425 to update the joint proxy statement/prospectus for its pending merger with Supernus, adding voluntary disclosures to moot shareholder litigation alleging disclosure deficiencies. The special stockholder meetings for both companies remain scheduled for October 15, 2026, and the deal terms are unchanged.
Key Financial Metrics
Key Facts
- Indivior and Supernus will each hold a special stockholder meeting on October 15, 2026 to vote on the merger.
- Supernus received demand letters and two complaints in New York state court alleging disclosure deficiencies in the joint proxy statement/prospectus.
- Indivior and Supernus voluntarily supplemented the proxy statement with additional financial advisor details (Cantor Fitzgerald analyses) to moot the litigation, without admitting liability.
- Cantor's DCF analysis for Indivior implied a dividend-adjusted per-share equity value range of $24.20 to $43.90.
- Cantor's DCF analysis for Supernus implied a per-share equity value range of $50.55 to $59.50.
- Indivior's estimated cash and debt were approximately $249 million and $500 million, respectively; Supernus had approximately $372 million cash and $0 debt.
- A $1 billion Special Dividend ($8.13/share) is contingent on merger closing.
- Post-merger, Indivior will be renamed Supernus, Inc.
Financial Impact
No new financial data or changes to deal value; supplemental disclosures only clarify existing financial advisor analyses. The $1 billion Special Dividend ($8.13/share) is contingent on closing.
Risk Factors
- Shareholder vote fails at either company's special meeting on October 15, 2026.
- Regulatory approvals or other closing conditions are delayed or not satisfied.
- Additional shareholder lawsuits or opposition could emerge despite the supplemental disclosures.
- The $1 billion Special Dividend increases Indivior's leverage, adding post-close balance sheet risk.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-113885 |
| Document: 0001104659-26-113885-index-headers.html | 0001104659-26-113885 |
| Document: 0001104659-26-113885-index.html | 0001104659-26-113885 |
| Document: 0001104659-26-113885.txt | 0001104659-26-113885 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 today | 425 | $34.39 | awaiting T+5 | awaiting T+5 | $35.21 (+2.38%) |
Oct 29, 2026 today | 8-K | No price | awaiting T+5 | awaiting T+5 | No price |
Oct 29, 2026 today | Press Release | $34.39 | awaiting T+5 | awaiting T+5 | $35.21 (+2.38%) |
Oct 20, 2026 8d ago | Institutional Cluster | $34.79 $34.72 | ▼ −0.20% | ▲ +0.24% | $35.21 (+1.21%) |
Oct 19, 2026 10d ago | Press Release | $33.87 | awaiting T+5 | awaiting T+5 | $35.21 (+3.96%) |
Oct 6, 2026 23d ago | 425 | $35.90 $35.42 | ▼ −1.34% | ▼ −1.20% | $35.21 (−1.92%) |
Oct 6, 2026 23d ago | 8-K | $35.90 $35.42 | ▼ −1.34% | ▼ −1.20% | $35.21 (−1.92%) |
Sep 30, 2026 28d ago | SC 13G | $35.38 $35.45 | ▲ +0.20% | ▼ −1.10% | $35.21 (−0.48%) |
Sep 17, 2026 6w ago | 425 | $35.69 $36.00 | ▲ +0.87% | ▲ +0.27% | $35.21 (−1.34%) |
Sep 17, 2026 6w ago | 8-K | $35.69 $36.00 | ▲ +0.87% | ▲ +0.27% | $35.21 (−1.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers